Christian Rabe

Dr. Christian Rabe


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2017 in Clinical Toxicology
Verified
Journal Article
Closed access
RBRegina Böll
Regina Böll
KRKatrin Romanek
Katrin Romanek
SSSabrina Schmoll
Sabrina Schmoll
RSRaphael Stich
Raphael Stich
AOArmin Ott
Armin Ott
CRChristian Rabe
Christian Rabe
Objective: To independently validate the predictive value of the intensive care requirement score (IRS) in unselected poisoned patients. Design: Retrospective chart review. Patients and methods: Five hundred and seventeen out of 585 admissions for acute intoxications could be analyzed. Eleven were excluded for a condition already requiring intensive care unit (ICU) support at admission (e.g., preclinical intubation). A further 57 admissions were excluded due to missing data. The IRS was calculated using a point-scoring system including age, Glasgow Coma Scale, heart rate, type of intoxication, and preexisting conditions. It was then compared to a composite endpoint indicating an ICU requirement (death in hospital, vasopressors, need for ventilation). The endpoint and the point-scoring system were identical to the original publication of the score. Results and conclusion: Twenty-three out of 517 patients had a complicated clinical course as defined by meeting the endpoint definition. Twenty-one out of 23 complicated courses had a positive IRS (defined as greater or equal 6 points), as compared to 255/494 patients with an uncomplicated clinical course (p < .001, Fisher’s exact test). One patient (with a positive IRS) died. The negative predictive value of the IRS was 0.99 (95% CI: 0.97–1), the sensitivity was 0.91 and the specificity 0.48. In conclusion, the IRS is significantly linked to outcome. While a negative IRS virtually excludes the need for ICU care, a positive IRS has a positive predictive value too low to be used for risk stratification. The IRS could also be applied to unselected admissions of poisoned patients.

9 June 2022 in Annals of General Psychiatry
Verified
Journal Article
Open access
PDF file
MLMaja Lumpe
Maja Lumpe
JSJohannes Schurr
Johannes Schurr
CRChristian Rabe
Christian Rabe
AOArmin Ott
Armin Ott
TZTobias Zellner
Tobias Zellner
SGStefanie Geith
Stefanie Geith
Objective: To identify the psychiatric profile of patients hospitalized due to self-intoxication associated with suicide-related behavior (SRB). Methods: In this retrospective single-center study, records of consecutive patients treated for suicidal poisoning in our Clinical Toxicology unit between 1st January 2012 and 31st December 2016, who received at least one psychiatric exploration during their inpatient stay, were analyzed with regard to epidemiological data, ingested substances, psychiatric and somatic comorbidities, suicidal circumstances and follow-up therapy. Results: Out of 1289 hospitalized patients, 1090 patients with complete data were analyzed. Mean age was 40.5 ± 17.2 years, 66.7% were female. 32.0% of patients had previously engaged in SRB, in 76.3% intention was suicidal. 64.7% of patients had a pre-existing psychiatric disorder (PD). Patients with a pre-existing PD more often displayed prior SRB than those without PD (40.7% vs 15.3%; p < 0.001; Fisher′s exact test), used long-term/on demand medication (70.2% vs 38.9%; p < 0.001), distanced themselves from the current suicide attempt (65.9% vs 50.8%; p < 0.001) and had no detectable trigger (38.7% vs 18.1%; p < 0.001). Partnership conflict was the most commonly named trigger, and it was documented more often in patients without than in those with PD (41.6% vs 25.6%). After psychiatric reevaluation, most patients were diagnosed with mood disorders (29.7%) and stress disorders (17.0%); 32.8% of patients had a combination of two or more PDs. Conclusion: Hospitalization due to self-poisoning is associated with pre-existing PD, prior SRB and access to psychiatric medication. Detection of these risk factors could allow timely introduction of effective preventive measures tailored to particularly vulnerable subgroups and appropriate relief. However, lack of a detectable trigger in many cases may hamper the identification of those at risk.

8 April 2022 in European Journal of Emergency Medicine
Verified
Journal Article
Closed access
EHEva-Carina Heier
Eva-Carina Heier
Florian EyerFlorian Eyer
Florian Eyer
CRChristian Rabe
Christian Rabe
SGStefanie Geith
Stefanie Geith
PDPaul I. Dargan
Paul I. Dargan
OGon behalf of the Euro-DEN Research Group
on behalf of the Euro-DEN Research Group
Background and importance: Patients who use recreational drugs frequently co-ingest ethanol, which is considered a central nervous system (CNS) depressant. The clinical relevance of this in acute toxicity involving other CNS depressants is not well described. Objective: To assess the clinical impact of ethanol co-use in patients presenting to the emergency department (ED) with acute toxicity involving the use of CNS depressant drugs. Design, settings and participants: A retrospective multicentre study using data from the Euro-DEN Plus database from January 2014 to December 2019. Outcomes measure and analysis: Comparison of epidemiologic and clinical characteristics, ED and hospital management of patients with CNS depressant intoxication with or without ethanol co-use. Main results: Although 7644 (17.5%) of the 43 633 presentations were included, ethanol was co-ingested in 3811 (49.9%). In total 53.3% required medical treatment, 14 patients died. Patients with ethanol co-use more frequently presented with a Glasgow Coma Scale (GCS) ≤8 (34.1% vs. 22.4%; P < 0.001), vomiting (8.1% vs. 4.6%; P < 0.001), anxiety (12 % vs. 6.4%; P < 0.001), agitation/aggression (22% vs. 14.7%; P < 0.001), seizures (3.8% vs. 2.4%; P < 0.001) and hypotension (7.5% vs. 4.6%; P < 0.001). They more often required ambulance transport (85.5% vs. 76.5%; P < 0.001), medical treatment (57.3% vs. 48.0%; P < 0.001), hospitalization (27.7% vs. 18.9%; P < 0.001), and admission to intensive care (12.2% vs. 4.0%; P < 0.001). Subgroup analysis showed that GCS ≤8 was particularly common in patients who combined ethanol with opioids or gamma-hydroxybutyrate (GHB)/gamma-butyrolactone (GBL). Conclusion: Co-use of ethanol with CNS-depressant drugs appears to increase the risk of adverse effects and is associated with a higher need for medical treatment, especially when ethanol is combined with opioids or GHB/GBL.

3 April 2023 in Clinical Toxicology
Verified
Journal Article
Closed access
SSSabrina Schmoll
Sabrina Schmoll
EHEva-Carina Heier
Eva-Carina Heier
RBRegina Böll
Regina Böll
TZTobias Zellner
Tobias Zellner
KRKatrin Romanek
Katrin Romanek
SGStefanie Geith
Stefanie Geith
To independently validate the predictive value of the Tanta University Risk Model for intensive care requirement in unselected poisoned patients.Retrospective chart review of 293 poisoned patients....

8 February 2021 in Clinical Toxicology
Verified
Journal Article
Closed access
MWMatthias Wacker
Matthias Wacker
JPJoerg Pietsch
Joerg Pietsch
RORainer Okrojek
Rainer Okrojek
SSSabrina Schmoll
Sabrina Schmoll
PHPetra Hoppmann
Petra Hoppmann
CRChristian Rabe
Christian Rabe
To the Editor, Colchicine inhibits microtubule assembly and cell division. Clinically, damage to rapidly dividing cells such as those responsible for myelopoiesis and bowel epithelium occurs [1]. A...

25 January 2022 in International Journal of Mental Health Systems
Verified
Journal Article
Open access
PDF file
SGStefanie Geith
Stefanie Geith
CDChristiane Didden
Christiane Didden
CRChristian Rabe
Christian Rabe
TZTobias Zellner
Tobias Zellner
AOArmin Ott
Armin Ott
Florian EyerFlorian Eyer
Florian Eyer
Background: Although the total number of suicides decreased since the beginning of the 1980s, the number of suicide-related behaviors using self-intoxication increased. Therefore, research on the characteristics of individuals committing self-intoxication becomes of growing importance for risk assessments and the development of preventive measures. Methods: In this prospective, observational, monocentric cohort study, all incoming calls at our Poisons Control Centre reporting suicide-related behaviors through self-intoxication, were analyzed via a standardized questionnaire over 12 months. Both univariate and bivariate analyses were performed. Results: 1238 cases of deliberate intoxication were included in the study. The majority of cases occurred in the age group between 18 and 44 (n = 607/49%), two-thirds were female (n = 817/66%). The main substances used were antidepressants (n = 420/34%), peripheral analgesics (n = 322/26%) and neuroleptics (n = 282/23%). The majority of patients ingested substances from their prescribed medication (n = 640/82%) with the highest proportion in those aged over 64 years (n = 72/113; 91%, p < 0.001). Substance use was reported for the minority of patients (n = 175/23%). For 704 cases (79%), a psychiatric disorder was documented. Factors associated with recurrent suicide-related behaviors were an underlying psychiatric disorder (OR = 6.2; 95% CI 3.8–10.4), substance use (OR = 2.4; 95% CI 1.5–3.8), and ingestion of neuroleptics (OR = 2.1, 95% CI 1.4–3.0) or antidepressants (OR = 1.6; 95% CI 1.2–2.3). Conclusion: This study might contribute to identifying individuals with an increased risk of suicide-related behaviors by deliberate intoxication and to developing preventive strategies for future suicide attempt(s).